| R2304380 |
DAUDA |
DAUDA (11-(dansylamino) undecanoic acid) is an environment-sensitive fluorescent
|
| R2304381 |
SR2640 |
SR2640 is a potent and selective competitive leukotriene D4/leukotriene E4 antag
|
| R2304382 |
SR2640 hydrochloride |
SR2640 (hydrochloride) is a potent and selective competitive leukotriene D4/leuk
|
| R2304383 |
PDE4B-IN-2;A 33 |
PDE4B-IN-2 is an orally active and selective PDE4B inhibitor with an IC50 of 15
|
| R2304384 |
Cediranib Maleate |
Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR
|
| R2304385 |
PF-4800567 |
PF-4800567 is a potent and selective inhibitor of casein kinase 1ϵ (CK1ϵ), with
|
| R2304386 |
WAY-658261 |
|
| R2304387 |
OfHex1-IN-2 |
OfHex1-IN-2 (compound I-79) is a potent β-N-acetylhexosaminidase OfHex1 inhibito
|
| R2304388 |
Trequinsin hydrochloride |
Trequinsin hydrochloride (HL 725) is an extremely potent inhibitor of platelet C
|
| R2304389 |
CLP257 |
CLP257 is a selective K+-Cl− cotransporter KCC2 activator with an EC50 of 616 nM
|
| R2304390 |
TC-MCH 7c |
TC-MCH 7c, a phenylpyridone derivative, is an orally available, selective and br
|
| R2304391 |
FTIDC |
FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glu
|
| R2304393 |
FMF-04-159-2 |
FMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2
|
| R2304394 |
Pedunculoside |
Pedunculoside exerts lipid-lowering effects partly through the regulation of lip
|
| R2304395 |
PF-06465469 |
PF-06465469 is a covalent inhibitor of ITK with an IC50 of 2 nM.
|
| R2304396 |
CATPB |
CATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist
|
| R2304397 |
NTRC-824 |
NTRC-824 (Compound 5) is a potent, selective and neurotensin-like nonpeptide neu
|
| R2304398 |
CGP-53353 (DAPH-7) |
CGP-53353 (DAPH-7) is an potent PKC inhibitor with IC50s of 0.41 mM and 3.8 mM f
|
| R2304401 |
Elacestrant dihydrochloride |
Elacestrant (RAD1901) dihydrochloride is an orally available and selective estro
|
| R2304402 |
Elacestrant |
Elacestrant (RAD1901) is an orally available and selective estrogen receptor deg
|
| R2304403 |
Almonertinib;HS-10296 |
Almonertinib (HS-10296) is an orally available, irreversible, third-generation E
|
| R2304404 |
CAY10603 |
CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2
|
| R2304405 |
PF1022A |
PF 1022A is a cyclooctadepsipeptide with broadspectrum anthelmintic properties p
|
| R2304406 |
Tulathromycin B |
Tulathromycin a macrolide antibiotic, inhibits protein synthesis (IC50=0.26 µM)
|
| R2304407 |
Pneumocandin B0 |
Pneumocandin B0(L-688786), a key intermediate in the synthesis of the antifungal
|